scholarly journals Clinical approaches to treat impaired awareness of hypoglycaemia

2021 ◽  
Vol 12 ◽  
pp. 204201882110002
Author(s):  
Catriona M. Farrell ◽  
Rory J. McCrimmon
Keyword(s):  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Impaired Awareness Of Hypoglycaemia ◽  
Clinical Strategies ◽  
Impaired Awareness ◽  
Low Glucose ◽  
Initial Focus

Impaired awareness of hypoglycaemia (IAH) affects between 25% and 30% of all people with type 1 diabetes (T1D) and markedly increases risk of severe hypoglycaemia. This greatly feared complication of T1D impairs quality of life and has a recognised morbidity. People with T1D have an increased propensity to hypoglycaemia as a result of fundamental physiological defects in their ability to respond appropriately to a fall in blood glucose levels. With repeated exposure to low glucose, many then develop a condition referred to as IAH, where there is a reduced ability to perceive the onset of hypoglycaemia and take appropriate corrective action. The management of individuals with IAH relies initially on its identification in the clinic through a detailed exploration of the frequency of hypoglycaemia and an assessment of the individual’s ability to recognise these episodes. In this review article, we will address the clinical strategies that may help in the management of the patient with IAH once identified, who may or may not also suffer from problematic hypoglycaemia. The initial focus is on how to identify such patients and then on the variety of approaches involving educational programmes and technological approaches that may be taken to minimise hypoglycaemia risk. No single approach can be advocated for all patients, and it is the role of the health care professional to identify the clinical strategy that best enables their patient to achieve this goal.

A Review of Type 1 Diabetes (T1D)

2020 ◽  
pp. 13-49
Author(s):  
Eileen O'Donnell ◽  
Liam O'Donnell
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Acting Insulin ◽  
Short Period ◽  
Sporting Activities ◽  
To Come

The diagnosis of Type 1 Diabetes (T1D) will come as an unwelcome surprise to most people. Within a short period of time, the person will have to come to understand and manage this chronic illness. The terminology associated with the T1D condition will also be totally new to the person: diabetes mellitus, pancreas, hyperglycaemia (hyper), hypoglycaemia (hypo), bolus (fast acting insulin), basal (slow acting insulin), ketones and blood glucose levels. The purpose of this article is to assist newly diagnosed patients' understanding of T1D, people who are already living with T1D, carers of people with T1D, partners and family members of someone with T1D, work colleagues, and friends who participate in the same sporting activities or go on holiday with a person who has T1D. In addition, this article reviews how people living with T1D can still enjoy exercise and maintain the best quality of life possible; whilst controlling the blood glucose levels in their body for the rest of their lives to prevent the onset of complications associated with diabetes.

A Review of Type 1 Diabetes (T1D)

2018 ◽  
Vol 8 (2) ◽  
pp. 14-45
Author(s):  
Eileen O'Donnell ◽  
Liam O'Donnell
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Acting Insulin ◽  
Short Period ◽  
Sporting Activities ◽  
To Come

The diagnosis of Type 1 Diabetes (T1D) will come as an unwelcome surprise to most people. Within a short period of time, the person will have to come to understand and manage this chronic illness. The terminology associated with the T1D condition will also be totally new to the person: diabetes mellitus, pancreas, hyperglycaemia (hyper), hypoglycaemia (hypo), bolus (fast acting insulin), basal (slow acting insulin), ketones and blood glucose levels. The purpose of this article is to assist newly diagnosed patients' understanding of T1D, people who are already living with T1D, carers of people with T1D, partners and family members of someone with T1D, work colleagues, and friends who participate in the same sporting activities or go on holiday with a person who has T1D. In addition, this article reviews how people living with T1D can still enjoy exercise and maintain the best quality of life possible; whilst controlling the blood glucose levels in their body for the rest of their lives to prevent the onset of complications associated with diabetes.

scholarly journals Acquired Acrodermatitis Enteropathica in a 28-Year-Old Male with Type 1 Diabetes

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Owen Ngalamika ◽  
Wencilaus M. P. Selvaraj ◽  
Fatima K. Yikona ◽  
Chibamba Mumba
Keyword(s):  
Type 1 Diabetes ◽  
Zinc Deficiency ◽  
Gastrointestinal Symptoms ◽  
Signs And Symptoms ◽  
Acrodermatitis Enteropathica ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Systemic Infections

Acrodermatitis enteropathica (AE) is a rare disorder arising from inherited or acquired zinc deficiency. It is mainly characterized by acral dermatitis, periorificial dermatitis, alopecia, and gastrointestinal symptoms in the form of diarrhea. There are many complications of AE including local and systemic infections that may develop as a result of untreated AE. In addition, due to the role of zinc in glucose metabolism, chronic zinc deficiency may pose a challenge in the control of blood glucose levels in diabetics. We report the case of a 28-year-old male with type 1 diabetes who presented with signs and symptoms of AE.

scholarly journals Cabaran Psikologi bagi Remaja yang Menghidap Diabetes Jenis 1

2018 ◽  
Vol 10 (3-2) ◽  
Author(s):  
Ariffi Suraya Rahmani ◽  
Azlina Mohd. Kosnin ◽  
Zakiah Mohamad Ashari
Keyword(s):  
Type 1 Diabetes ◽  
Children And Adolescents ◽  
Diabetes Management ◽  
Public Access ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Negative Effect ◽  
Life Type

Managing a chronic disease is very challenging and requires effective coping strategies to overcome difficulties for maintaining the health and stability of quality of life. Type 1 diabetes is one of the most common chronic diseases in children and adolescents that requires complex treatment and care. Type 1 diabetes management aspects include insulin intake, checking blood glucose levels, monitoring risk and treatment of disease complications, dietary intake, and physical activity. In addition, the lack of understanding of diabetes among family members and friends also makes them difficult to adapt to the disease and can cause them to experience psychological problems and stress. Hence, this paper aims to identify the psychological challenges faced by children and adolescents with type 1 diabetes. The study is conducted by review the literature on 9 published articles from 2010 to 2017 obtained from the Science Direct, SAGE, PubMed and NIH Public Access. The findings have identified several aspects of psychology often experienced by children and adolescents with type 1 diabetes such as depression, anxiety, stress, and distress. This psychological condition can have a negative effect on life skills, glucose control and ability to deal with diabetes management. It is hoped that proper management in encountering psychological challenges will lead to better results.

The role of blood glucose self-monitoring in assessing glycemic variability in patients with type 1 diabetes mellitus

2021 ◽  
Vol 22 (2) ◽  
pp. 152-155
Author(s):  
A. S. Sudnitsyna ◽  
◽  
L. A. Suplotova ◽  
N. V. Romanova ◽  
◽  
...  
Keyword(s):  
Blood Glucose ◽  
Glycemic Variability ◽  
Self Monitoring ◽  
Glucose Levels ◽  
Treatment And Prevention ◽  
Blood Glucose Levels ◽  
Patients With Diabetes ◽  
Blood Glucose Self Monitoring

In the context of the increasing prevalence of diabetes, an important task is to educate the patient on the mandatory self-monitoring of blood glucose levels (SMBG), which is an integral component of the treatment and prevention of acute and chronic complications of the disease. On the basis of the SMBG data, it is possible to assess the parameters of glycemic variability, which is the fluctuations in blood glucose during the day and differences in blood glucose levels at the same time on different days. Due to the fact that GV is one of the main criteria for assessing the quality of glycemic control, its correction is considered as a new goal in the treatment of patients with diabetes.

776-P: Characteristics of Overnight Blood Glucose Levels Are Related to Sleep Quality in People with Type 1 Diabetes

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 776-P
Author(s):  
RACHEL BRANDT ◽  
MINSUN PARK ◽  
LAURIE T. QUINN ◽  
MINSEUNG CHU ◽  
YOUNGKWAN SONG ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Sleep Quality ◽  
Glucose Levels ◽  
Blood Glucose Levels

Antidiabetic effect of Psychotria malayana Jack in induced type 1 diabetic rat

MEDISAINS ◽  
2020 ◽  
Vol 18 (1) ◽  
pp. 19
Author(s):  
Fairuz Fairuz ◽  
Hasna Dewi ◽  
Humaryanto Humaryanto
Keyword(s):  
Blood Glucose ◽  
Side Effects ◽  
Type I Diabetes ◽  
Langerhans Cell ◽  
Diabetic Rat ◽  
Type I ◽  
Antidiabetic Effect ◽  
Glucose Levels ◽  
Blood Glucose Levels

Background: Therapies for hyperglycemic treatment, including insulin and oral diabetes medications, have been confirmed to cause several side effects. Thus, finding new drugs with fewer side effects is of high importance. Salung leaf herb (Psychotria malayana Jack) reported used in traditional societies as a treatment for diabetes. However, the scientific proof of this plant for diabetes treatment is still lacking.Objective: To evaluate the antidiabetic effect of the P. malayana jack in induced type 1 diabetic rats by assessing blood glucose level and pancreatic cells in white rats.Methods: Alloxan used to induce type I diabetes. Rats randomly divided into six groups. A Group P1 received 250 mg/kg BW; group P2 received 500 mg/kg BW, group P3 received 1000 mg/kg BW. While group 4 basal received no treatment, group 5 received distilled water as a negative control, and group 6 received glibenclamide as a positive control. Medications are given for six days. Glucose levels were measured, and observation of pancreatic Langerhans cell damages.Results:  A decrease in blood glucose levels observed in all treatment groups. The most significant reduction (49.76%; 1000 mg/kg BW) occurred in the P3 group. Morphological features of pancreatic Langerhans cell damage were slightly high in the P1 group.Conclusion: P. malayana Jack can consider having an antidiabetic effect in a type 1 diabetic rat by reducing blood glucose levels.

Can Innovative Technologies Overcome HbA1c Disparity for African-American Youth with Type 1 Diabetes?

2021 ◽  
pp. 193229682110213
Author(s):  
Stuart Chalew ◽  
Alan M. Delamater ◽  
Sonja Washington ◽  
Jayalakshmi Bhat ◽  
Diane Franz ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Racial Disparity ◽  
Diabetes Management ◽  
New Technology ◽  
African American Youth ◽  
Glucose Monitoring ◽  
Supportive Role

Achieving normal or near-normal glycemic control as reflected by HbA1c levels in patients with type 1 diabetes (T1D) is important for preventing the development and progression of chronic complications. Despite delineation and dissemination of HbA1c management targets and advances in insulin pharmacology, insulin delivery systems, and glucose monitoring, the majority of children with T1D do not achieve HbA1c goals. In particular, African Americans are more likely not to reach HbA1c goals and have persistently higher HbA1c than Non-Hispanic Whites. Availability of pumps and other technology has not eliminated the disparity in HbA1c. Multiple factors play a role in the persisting racial disparity in HbA1c outcome. The carefully designed application and deployment of new technology to help the patient/family and facilitate the supportive role of the diabetes management team may be able to overcome racial disparity in glycemic outcome and improve patient quality of life.

Sign in / Sign up

Export Citation Format

Share Document